Repurposing the multiple sclerosis drug Siponimod for osteoporosis treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repurposing the multiple sclerosis drug Siponimod for osteoporosis treatment

Published:2024-07 Issue: Volume:974 Page:176630
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Hu Sitao^ORCID,Hu Yangyang,Tan Zenglin^ORCID,Zhou Chengyu,Zhang Cheng,Yin Sheng,Chen Xiaojun,Chen Kai,Wang Lu,Chen Lei^ORCID

Funder

National Natural Science Foundation of China

Zhejiang Province Natural Science Foundation

Wenzhou Municipal Science and Technology Bureau

Publisher

Elsevier BV

Reference35 articles.

1. Dissecting the role of the S1P/S1PR axis in health and disease;Aarthi;J. Dent. Res.,2011

2. Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5;Behrangi;Proc. Natl. Acad. Sci. U. S. A.,2022

3. Clinical practice. Postmenopausal osteoporosis;Black;N. Engl. J. Med.,2016

4. Osteoclast differentiation and activation;Boyle;Nature,2003

5. Osteoporosis;Compston;Lancet,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP